儿童多药耐药结核病:流行病学,诊断,治疗和预防的实用更新
James T Gaensbauer1,2, Nabaneeta Dash3, Sanjay Verma4
1Mayo Clinic Center for Tuberculosis, Mayo Clinic, Rochester, MN, USA.
概括
儿童多耐药结核病 (MDR-TB) 诊断和治疗面临挑战,但新的快速测试和更短的全口服药物治疗方案为儿童提供了更好的结果的希望. 需要进一步的儿科试验以获得最佳的管理.
科学领域:
- 儿童传染病 儿童传染病
- 菌株学 菌株学 菌株学
- 全球卫生健康 全球卫生健康
背景情况:
- 儿科多药耐药结核病 (MDR-TB) 是一个关键的全球卫生问题,存在重大诊断和治疗障碍.
- 据估计,每年有不到5%的儿科MDR-TB病例是微生物确诊的,导致结果差,死亡率增加.
- 传统的MDR-TB治疗方案是漫长的,涉及多种药物,通常包括有毒的注射剂.
研究的目的:
- 审查儿童MDR-TB的诊断和治疗方面的最新进展.
- 突出在儿童中识别,确认和管理MDR-TB的挑战.
- 讨论新药和治疗方案的潜力,以改善患有MDR-TB的儿童的治疗结果.
主要方法:
- 关于儿科MDR-TB诊断和治疗的当前文献的综述.
- 案例说明管理挑战和潜在的成功.
- 讨论新兴的快速分子测试和新药疗法.
主要成果:
- 快速分子测试的利法敏感性正在变得可用,但面临的样本采集和 paucibacillary性质的挑战在儿童中.
- 新的药物,如贝达基林,德拉曼尼德,克洛法齐明和莱因佐利德,可实现更短,全口服的MDR-TB治疗方案.
- 目前对于幼儿短时间全口服治疗方案 (包括普雷托曼尼德) 的数据不够.
结论:
- 诊断和治疗方面的进步为改善儿科MDR-TB管理提供了希望.
- 儿童临床试验对于评估新药和MDR-TB治疗方案至关重要.
- 优化诊断和治疗对于降低死亡率和改善MDR-TB儿童的治疗结果至关重要.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.8K
相关概念视频
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis IV
139
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
139
Pulmonary Tuberculosis I
240
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
240
Pulmonary Tuberculosis III
322
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
322
Pulmonary Tuberculosis II
223
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
223
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
